Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
Holding LEGN?
Track your performance easily

Legend Biotech (LEGN) Financial Statements

312 Followers

Legend Biotech Financial Overview

Legend Biotech's market cap is currently ―. The company's EPS TTM is $-1.566; its P/E ratio is -30.68; Legend Biotech is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue--$ 11.97M$ 40.83M$ 38.99M
Gross Profit--$ -4.97M--
EBIT--$ -191.43M$ -40.09M$ -87.73M
EBITDA--$ -191.43M$ -36.17M$ -84.02M
Net Income Common Stockholders--$ -193.23M$ -41.09M$ -88.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.28B$ 786.03M$ 783.11M$ 791.26M$ 882.39M
Total Assets$ 1.85B$ 1.33B$ 1.02B$ 1.04B$ 1.12B
Total Debt$ 383.94M$ 284.53M$ 195.72M$ 129.23M$ 122.97M
Net Debt$ -893.77M$ -501.50M$ -587.39M$ -662.03M$ -759.43M
Total Liabilities$ 597.24M$ 1.33B$ 460.11M$ 601.95M$ 647.16M
Stockholders Equity$ 1.25B$ 744.31M$ 562.63M$ 438.56M$ 471.21M
Cash Flow-
Free Cash Flow---$ -91.22M$ -72.70M
Operating Cash Flow---$ -78.69M$ -69.55M
Investing Cash Flow---$ -232.50M$ 96.51M
Financing Cash Flow---$ 25.00K$ 323.56M
Currency in USD

Legend Biotech Earnings and Revenue History

Legend Biotech Debt to Assets

Legend Biotech Cash Flow

Legend Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis